Countries: USA ▼

UPDATE to Shortage of US-labeled TRANXENE T-TAB® Tablets (clorazepate dipotassium tablets, USP) 7.5 mg

09/05/2019

Download PDF

 

September 4th, 2019 (Update to Trade Letter dated June 6th , 2019)

 

Dear Trade Partner,

 

This is to inform you that a new lot of Tranxene T-Tab Tablets (clorazepate dipotassium tablets, USP) 7.5mg, NDC 55292-304-01 presented as 100ct bottles has been successfully manufactured and releases for distribution. Cardinal Health SPS will resume fulfilling all open Tranxene orders today.

As always, we greatly appreciate your business and your support. Should you have any questions please contact Paul Stickler, V.P. of Commercial Operations at Stickler.P@Recordati.com or call (847) 205-5503. 

 

Regards,

Paul Stickler, V.P. Commercial Operations

 

T-Tabs is a Registered Trademark of Recordati Rare Diseases. Inc.